News & Updates

The fatty acid synthase inhibitor denifanstat shows potential for treating moderate-to-severe acne vulgaris, with good safety and tolerability, as demonstrated in a study from China presented at EADV 2025.

Influenza affects 5-15 percent of the population in Malaysia each year, resulting in serious complications such as pneumonia, and worsening of underlying conditions including asthma, chronic obstructive pulmonary disease, and congestive heart failure.